← Back to Influence Map
Entity DossierOrganization
SANOFI U.S. SERVICES, INC.
DC · US
Multinational Pharmaceutical Company.
pharmaceuticals
Tracked direct giving
$0
LDA reported lobbying spend
$760,000
Connections
4
Lobbying Activity Detail
Disclosed lobbying expenditures from LDA filings where this entity is the client. Dollar amounts represent what was reported to the Senate Office of Public Records.
Top Lobbying Issues
MMMMedicare/Medicaid
$700KTRDTrade
$660KTAXTaxation/Internal Revenue Code
$660KPHAPharmacy
$660KCPTCopyright/Patent/Trademark
$660KHCRHealth Issues
$400KBUDBudget/Appropriations
$120KLobbying Firms Retained
W STRATEGIES, LLC$700K
MARSHALL & POPP, LLC$660K
Lobbying data from Senate LDA filings and the LobbyView dataset (MIT/NSF, CC-BY-4.0). Dollar figures represent disclosed expenditures only and may not capture all influence activity. Issue codes follow the LDA general issue classification.
Connection Graph
0 nodes · 0 edgesHover for labels · Double-click to expand
Loading graph...
Person
Organization
PAC
Gov Body
Legislature
Think Tank
Industry
Outcome
Click a node to see details
Double-click to expand its connections
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Lobbied on | Pharmacy Benefit Manager Reform Act | LDA filing: lobbied on PBM Reform Act, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000 | Source |
| Retained | MARSHALL & POPP, LLC | Hired MARSHALL & POPP, LLC to lobby on PBM Reform Act | Source |
| Lobbied on | Insulin Price Caps - State-Level Legislation | LDA filing: lobbied on Insulin Price Caps, period 1st Quarter (Jan 1 - Mar 31), reported amount $60,000 | Source |
| Retained | W STRATEGIES, LLC | Hired W STRATEGIES, LLC to lobby (1st Quarter (Jan 1 - Mar 31) 2023) | Source |